Senior insider sale
EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC — senior position signals high conviction
$4.47M
60.85K shares
What this filing means
KORDASIEWICZ HOLLY B. plans to sell 60.85K shares of IONIS PHARMACEUTICALS INC valued at approximately $4.47M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/12/2026ACC: 0001972481-26-000192
Officer· EVP, Chief Development Officer
Since Dec 2025
60.85K
Shares to sell
$4.47M
Approx. market value
60.85K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Option Exercise
Equity Compensation
1/3/2022
12KOption Exercise
Equity Compensation
1/4/2021
19.89KOption Exercise
Equity Compensation
1/2/2020
28.95KTotal acquired60.85K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/3/2022 | Option Exercise Equity Compensation | 12K | — |
1/4/2021 | Option Exercise Equity Compensation | 19.89K | — |
1/2/2020 | Option Exercise Equity Compensation | 28.95K | — |
| Total | 60.85K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
60.85K
Market value
$4.47M
6/12/2026
Total
Units
60.85K
Value
$4.47M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/12/2026 | 60.85K | $4.47M | Nasdaq | Planned |
| Total | 60.85K | $4.47M | ||